Next Article in Journal
Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer
Next Article in Special Issue
Peculiarities of the Super-Folder GFP Folding in a Crowded Milieu
Previous Article in Journal
Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type
Previous Article in Special Issue
Benzbromarone, Quercetin, and Folic Acid Inhibit Amylin Aggregation
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2016, 17(9), 1428;

A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation

Chemistry Department and Coimbra Chemistry Centre, Faculty of Science and Technology, University of Coimbra, Coimbra 3004-535, Portugal
Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra 3004-504, Portugal
Health Research Unit, School of Health Sciences, Leiria 2411-901, Portugal
Author to whom correspondence should be addressed.
Academic Editor: Salvador Ventura
Received: 27 June 2016 / Revised: 18 August 2016 / Accepted: 23 August 2016 / Published: 31 August 2016
(This article belongs to the Collection Protein Folding)
Full-Text   |   PDF [1460 KB, uploaded 31 August 2016]   |  


Protein aggregation into insoluble amyloid fibrils is the hallmark of several neurodegenerative diseases, chief among them Alzheimer’s and Parkinson’s. Although caused by different proteins, these pathologies share some basic molecular mechanisms with familial amyloidotic polyneuropathy (FAP), a rare hereditary neuropathy caused by amyloid formation and deposition by transthyretin (TTR) in the peripheral and autonomic nervous systems. Among the amyloidogenic TTR mutations known, V30M-TTR is the most common in FAP. TTR amyloidogenesis (ATTR) is triggered by tetramer dissociation, followed by partial unfolding and aggregation of the low conformational stability monomers formed. Thus, tetramer dissociation kinetics, monomer conformational stability and competition between refolding and aggregation pathways do play a critical role in ATTR. Here, we propose a new model to analyze the refolding kinetics of WT-TTR and V30M-TTR, showing that at pH and protein concentrations close to physiological, a two-step mechanism with a unimolecular first step followed by a second-order second step adjusts well to the experimental data. Interestingly, although sharing the same kinetic mechanism, V30M-TTR refolds at a much slower rate than WT-TTR, a feature that may favor the formation of transient species leading to kinetic partition into amyloidogenic pathways and, thus, significantly increasing the probability of amyloid formation in vivo. View Full-Text
Keywords: transthyretin; WT-TTR; V30M-TTR; folding kinetics; amyloid; FAP; ATTR transthyretin; WT-TTR; V30M-TTR; folding kinetics; amyloid; FAP; ATTR

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Jesus, C.S.H.; Almeida, Z.L.; Vaz, D.C.; Faria, T.Q.; Brito, R.M.M. A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation. Int. J. Mol. Sci. 2016, 17, 1428.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top